Lornoxicam is an NSAID indicated in the treatment of mild to moderate pain, as well as rheumatoid arthritis and osteoarthritis. Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.
- Mechanism
- Curator reviewed
Like other NSAIDS, lornoxicam's anti-inflammatory and analgesic activity is related to its inhibitory action on prostaglandin and thromboxane synthesis through the inhibition of both COX-1 and COX-2. This leads to the reduction of inflammation, pain, fever, and swelling, which are mediated by prostaglandins. However, the exact mechanism of lornoxicam, like that of the other NSAIDs, has not been fully determined.
- Primary indication
- For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.Curator reviewed · 3 structured indications
- Formula / weight
- C13H10ClN3O4S2 · 371.81 g/mol (avg)
- Also known as
- Chlortenoxicam
- Code names
- CCRIS 8589 · Ro 13-9297
Resolves to
WLHQHAUOOXYABV-UHFFFAOYSA-NSMILESCN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=OWhat you can answer from here — as of June 15, 2026
Which drugs share a target with Lornoxicam, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account